{"database": "lobbying", "table": "lobbying_activities", "rows": [[2467949, "1348a79c-aa7b-4bee-9edc-6776bdee273b", "Q2", "TRAVERE THERAPEUTICS", 401104190, "TRAVERE THERAPEUTICS", 2020, "second_quarter", "CPT", "H.R. 990 and S. 344, the Hatch-Waxman Integrity Act; S. 1416, Affordable Prescriptions for Patients Act of 2019: H.R. 3991, Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act of 2019; H.R. 4398, Affordable Prescriptions for Patients Through Promoting Competition Act of 2019; Senate amendment to H.R. 2486", "Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE", null, 150000, 0, 0, "2020-07-16T11:28:25.487000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2467949"], "units": {}, "query_ms": 0.3530920948833227, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}